SCHEMBL6926913

SCHEMBL6926913

Cc1cccc(C(=O)Nc2cc(C(=N)N)sc2C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
KCNK3 O14649 3/20 0.50
KCNK9 Q9NPC2 3/20 0.50
KCNH2 Q12809 1/20 0.50
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
KDM4E B2RXH2 2/20 0.47
POLB P06746 2/20 0.47
TP53 P04637 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
MAPT P10636 1/20 0.46
NT5E P21589 1/20 0.46
FLT3 P36888 1/20 0.46
SCD O00767 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246338 0.86 KMT2A (0.53) KMT2AMEN1KCNK3KCNK9KCNH2
SCHEMBL6923975 0.81 KMT2A (0.56) KMT2AMEN1KCNK3KCNK9KCNH2
SCHEMBL6924665 0.73 PLAU (0.56) KMT2ANPC1RAB9ATP53MAPT
SCHEMBL13709501 0.72 PLAU (0.54) NPC1RAB9APARP1
SCHEMBL6923971 0.72 ALDH1A1 (0.54) KMT2AMEN1KCNK3KCNK9KCNH2
SCHEMBL6920041 0.72 MEN1 (0.56) KMT2AMEN1KCNK3KCNK9ALDH1A1
SCHEMBL6924791 0.72 C1S (0.53)
SCHEMBL21974461 0.70 KMT2A (0.68) KMT2AMEN1KCNK3KCNK9KCNH2
SCHEMBL20393318 0.70 KMT2A (0.73) KMT2AMEN1KCNK3KCNK9KCNH2
SCHEMBL18773840 0.70 KMT2A (0.84) KMT2AMEN1KCNK3KCNK9KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515002-B2 4-(4-(1-phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5 -methylthiothiophene-2-carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-02-04 US disclosed